TriLink is biotech company supplying RNA and DNA oligonucleotides for pre-clinical research and specialized in highly modified oligos, including RNA oligonucleotides and derivatives (2′ Fluoro RNA, 2′ O-Methyl RNA, etc…).
TriLink is biotech company supplying RNA and DNA oligonucleotides for pre-clinical research and specialized in highly modified oligos, including RNA oligonucleotides and derivatives (2′ Fluoro RNA, 2′ O-Methyl RNA, etc…).
DNA-directed RNA Interference (ddRNAi) is Benitec’s RNAi platform for gene silencing, with several advantages over other methods of gene silencing such as siRNA, anti-sense and zinc finger nucleases.
DLVR Therapeutics is developing an innovative, HDL-like Peptide-Phospholipid Scaffold (HPPS) nanoparticle delivery system, initially for RNAi therapeutics.